Year-end Sale % OFF 
Abstract
An inhibitor of glucose utilization in rat diaphragm was isolated from the serum of patients suffering from liver cirrhosis. This inhibitor is suggested to contribute to abnormal carbohydrate metabolism in liver diseases. It is a low molecular weight substance, probably of pepticle nature. It is identical with the inhibitor of glucose utilization isolated from the serum and urine of patients with renal failure and from the urine of healthy subjects.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
